Research progress in thoracic radiotherapy dosage-fractionation patterns for limited-stage small cell lung cancer
10.3760/cma.j.cn113030-20240829-00339
- VernacularTitle:局限期小细胞肺癌的胸部放疗剂量-分割模式研究进展
- Author:
Zehua SUN
1
;
Jingcong PAN
;
Sunjing QIANG
;
Xiao HU
Author Information
1. 温州医科大学研究生培养基地（浙江省肿瘤医院），杭州 310022
- Publication Type:Journal Article
- Keywords:
Small cell lung carcinoma;
Limited stage;
Thoracic radiotherapy;
Hypofractionation;
Hyperfractionation;
Conventional fractionation
- From:
Chinese Journal of Radiation Oncology
2025;34(7):718-723
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer (SCLC) is a highly malignant, rapidly progressing, poorly prognostic, and highly recurrent difficult-to-treat tumor. For more than 30 years, patients with limited-stage SCLC have been treated with a combination of thoracic radiotherapy and chemotherapy. For those who achieve good response, prophylactic cranial irradiation is recommended. But there is no consensus on the optimal dosage-fractionation for thoracic radiotherapy in limited-stage SCLC. In this article, a series of related studies conducted in recent years were reviewed.
